0001171843-24-001460.txt : 20240319
0001171843-24-001460.hdr.sgml : 20240319
20240319171745
ACCESSION NUMBER: 0001171843-24-001460
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colleran David
CENTRAL INDEX KEY: 0001646558
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 24765004
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY PARK DRIVE
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0508
4
2024-03-15
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001646558
Colleran David
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
EVP, General Counsel, Corp Sec
0
Restricted Stock Unit
0.00
2024-03-15
4
A
0
19345
0
A
Common Stock
19345
19345
D
Stock Option (Right to Buy)
27.98
2024-03-15
4
A
0
46875
0
A
2034-03-11
Common Stock
46875
46875
D
Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025.
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
The premium priced stock options vest in three equal annual installments beginning on March 15, 2025.
/s/ David Colleran
2024-03-19